PAM
FLNA

Premier Asset Management’s Filana Therapeutics FLNA Stock Holding History

Premier Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,852
Closed -$1.35M – 190
2021
Q2 		$1.35M Buy
15,852
+1,362
+9% +$73K 0.2% 79
2021
Q1 		$652K Sell
14,490
-63,762
-81% -$2.51M 0.12% 105
2020
Q4 		$534K Buy
78,252
+41,463
+113% +$370K 0.11% 102
2020
Q3 		$423K Buy
+36,789
New +$166K 0.11% 91

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Premier Asset Management's FLNA Position: Q3 2021 in Review

Premier Asset Management sold out of Filana Therapeutics (FLNA) in Q3 2021, closing a stake of 15,852 shares — an estimated $1.35M sold.

Premier Asset Management first reported a position in FLNA in Q3 2020 and held it in 4 quarters. The position peaked at $1.35M in Q2 2021. 180 funds tracked by Wall St. Rank hold FLNA as of Q3 2021.

  • Premier Asset Management reported no remaining Filana Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Premier Asset Management sold 15,852 Filana Therapeutics shares in Q3 2021, an estimated $1.35M.
  • Premier Asset Management first reported a position in Filana Therapeutics in Q3 2020 and held it in 4 quarters.
  • Premier Asset Management's Filana Therapeutics position peaked at $1.35M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2021.

Based on Premier Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.